SCHEMBL257632

SCHEMBL257632

Bc1ccc(-c2ccc(F)cc2)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
PTGS2 P35354 5/20 0.39
PTGS1 P23219 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
ALDH1A1 P00352 1/20 0.39
DHFR P00374 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
LMNA P02545 1/20 0.39
TTR P02766 1/20 0.39
ALB P02768 1/20 0.39
HMGB1 P09429 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19993198 0.89 ESR1 (0.38) APPCYP3A4CYP2C9CYP2C19PTGS2
SCHEMBL19993062 0.87 ESR1 (0.41) APPCYP3A4CYP2C9CYP2C19PDE3B
SCHEMBL12445903 0.83 PDE3B (0.39) PDE3BPDE3APTGS2KDM4EMEN1
SCHEMBL16104369 0.83 LMNA (0.46) CYP2C9CYP2C19PDE3BPDE3APTGS2
SCHEMBL9057929 0.81 ALDH1A1 (0.52) APPCYP3A4CYP2C9CYP2C19PDE3B
SCHEMBL19993178 0.80 ESR1 (0.38) APPCYP3A4CYP2C9CYP2C19PDE3B
SCHEMBL23252421 0.74 APP (0.41) APPCYP3A4CYP2C9CYP2C19PDE3B
SCHEMBL257801 0.74 ACHE (0.50) APPCYP3A4CYP2C9CYP2C19PDE3B
SCHEMBL21497175 0.74 PTGS2 (0.43) APPCYP3A4CYP2C9CYP2C19PDE3B
SCHEMBL20898100 0.74 NPC1 (0.49) APPCYP3A4CYP2C9CYP2C19PDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2399585-A1 Boronic acids and esters as inhibitors of fatty acid amide hydrolase Infinity Pharmaceuticals, Inc. (US) 2011-12-28 EP disclosed